Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response:: an in vivo and in vitro study

被引:10
作者
Satoi, S
Kitade, H
Hiramatsu, Y
Kwon, AH
Takahashi, H
Sekiguchi, K
Uehara, M
Oda, M
Yanagimoto, Y
Miyashita, K
Sakashita, E
Kamiyama, Y
机构
[1] Kansai Med Univ, Dept Surg 1, Osaka 5708507, Japan
[2] Kansai Med Univ, Dept Clin Sci & Lab Med, Osaka 5708507, Japan
[3] Osaka Univ, Inst Prot Res, Osaka, Japan
[4] Otsuka Pharmaceut Co Ltd, Tokushima 77101, Japan
来源
SHOCK | 2000年 / 13卷 / 06期
关键词
hepatocyte; fibroblast; sepsis; culture; cytokine; interleukin-1; tumor necrosis factor-alpha; interleukin-6;
D O I
10.1097/00024382-200006000-00012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A massive inflammatory reaction resulting from systemic cytokine release is the common pathway underlying sepsis or multiple organ dysfunction. The role of extra domain sequence A-containing fibronectin (EDA+FN) formation during the septic response is not known. The present study investigates the role of EDA+FN during the septic response under in vitro and in vivo conditions. The direct effects of interleukin-1, interleukin-6, and tumor necrosis factor-alpha on EDA+FN production were evaluated in primary cultured human hepatocytes and fibroblasts. Serial plasma EDA+FN levels were measured using an enzyme-linked immunosorbent assay in 24 patients who developed postoperative sepsis following general abdominal surgery of which there were 17 survivors and 7 non-survivors. EDA+FN secretion was significantly increased in cultured hepatocytes but not fibroblasts at 24 and 48 h following exposure to IL-1 compared to controls. In the clinical setting plasma EDA+FN levels in non-survivors were significantly higher than in survivors. Moreover, the EDA+FN levels were correlated closely with liver function tests. EDA+FN levels may represent a specific marker of vascular injury or systemic inflammatory response syndrome that is associated with an adverse clinical outcome.
引用
收藏
页码:492 / 496
页数:5
相关论文
共 28 条
[1]  
[Anonymous], 1991, CELL BIOL EXTRACELLU
[2]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[3]  
COLVIN RB, 1989, FIBRONECTIN, P213
[4]   PROTEOLYSIS OF GELATIN-BOUND FIBRONECTIN BY ACTIVATED LEUKOCYTES - A ROLE FOR LEUKOCYTE ELASTASE [J].
DAUDI, I ;
GUDEWICZ, PW ;
SABA, TM ;
CHO, E ;
VINCENT, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (04) :331-340
[5]   EDA-CONTAINING FIBRONECTIN IS SYNTHESIZED FROM RHEUMATOID SYNOVIAL FIBROBLAST-LIKE CELLS [J].
HINO, K ;
SHIOZAWA, S ;
KUROKI, Y ;
ISHIKAWA, H ;
SHIOZAWA, K ;
SEKIGUCHI, K ;
HIRANO, H ;
SAKASHITA, E ;
MIYASHITA, K ;
CHIHARA, K .
ARTHRITIS AND RHEUMATISM, 1995, 38 (05) :678-683
[6]  
HIRANO H, 1992, J CLIN LAB INSTRUM R, V15, P179
[7]   QUANTIFICATION OF CELL-NUCLEI ISOLATED FROM HEPATOCYTES BY CELL-LYSIS WITH NONIONIC DETERGENT IN CITRIC-ACID [J].
HORIUTI, Y ;
OGISHIMA, M ;
YANO, K ;
SHIBUYA, Y .
CELL STRUCTURE AND FUNCTION, 1991, 16 (03) :203-207
[8]  
Hynes R. O., 1990, FIBRONECTINS
[9]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829
[10]  
Korner T, 1996, HEPATOLOGY, V23, P423